(44 days)
Not Found
Not Found
No
The document describes a mechanical implant system for hip arthroplasty and does not mention any software, algorithms, or data processing capabilities that would indicate the use of AI or ML.
Yes
The device is a component of a total hip arthroplasty system, which is intended for the treatment of various joint diseases, pain, deformity, and dysfunction, clearly indicating a therapeutic purpose.
No
The device is an acetabular system used in total hip arthroplasty, which is a reconstructive surgical procedure, not a diagnostic one. It is designed to replace or revise components of the hip joint.
No
The device description clearly outlines physical components made of Ti-6A1-4V and commercially pure titanium, including shells, screwhole plugs, and pegs, which are hardware implants for total hip arthroplasty.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is for use in total hip arthroplasty to treat conditions affecting the hip joint. This is a surgical procedure performed directly on the patient's body.
- Device Description: The description details the components of an acetabular system, which are implants designed to be surgically placed in the hip socket.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens (like blood, urine, or tissue) outside of the body to provide information for diagnosis, monitoring, or screening.
IVD devices are used to perform tests on samples taken from the body, while this device is a surgical implant used to replace a damaged joint.
N/A
Intended Use / Indications for Use
Components of the Converge Acetabular System are intended for use in total hip arthroplasty for treatment of the following:
- patient conditions of noninflammatory degenerative joint disease (NIDJD); e.g., avascular ● necrosis, osteoarthritis, and inflammatory joint disease (IJD), e.g., rheumatoid arthritis.
- those patients with failed previous surgery where pain, deformity, or dysfunction persists. ●
- revision of a previously failed arthroplasty where there is sufficient bone stock to support the . implant.
Product codes (comma separated list FDA assigned to the subject device)
JDI, LPH
Device Description
The Converge Acetabular System consists of the following shell components:
- I. Hemispherical
The Converge Hemispherical Shell is a porous coated, Ti-6A1-4V (ASTM F136) shell. The outer surface of the shell has CSTi porous coating (commercially pure titanium) to provide for biological fixation. The shell is available in various sizes ranging from 39mm to 65mm (in 2mm increments).
The shell features 2 screwhole plugs that are sintered in place. The screwhole plugs can be removed intraoperatively before or after implantation if the surgeon opts to enhance fixation of the shell with bone screws. When left in place (no supplemental screws used), the screwhole plugs limit material ingress and egress (e.g., tissue, debris particles, cement, etc.).
- II. Rim-Flare
The Converge Rim Flare Shell is a Ti-6AI-4V metallic acetabular shell coated with CSTi porous coating. It is designed with an offset outer radius in the rim region which permits the loads to be transmitted to the periphery of the outer surface. An initial press-fit of the component is achieved by the offset radius in this region. Additionally, the outer design of the shell incorporates three pegs which are press-fit into the cancellous bone of the reamed acetabulum to minimize the potential for tilting or rotation of the device. The shell is available in various sizes ranging from 39mm to 71mm (in 2mm increments).
III. Revision
The Converge Revision Shell is a Ti-6Al-4V metallic acetabular shell coated with CSTi porous coating. The Revision shell has up to nine screwholes which allow for screw placement into the illum, ischium and pubis. Those screwholes that are not utilized may be plugged after implantation to limit passage of tissue, debris particles, cement, etc. The shell is available in various sizes ranging from 43mm (in 2mm increments).
All three Converge shells feature a central dome hole which allows for interface with the impactor/alignment instrument as well as for visualization of the acetabulum to ensure complete seating of the device. The dome hole may be plugged using a threaded cover to restrict unwanted material migration through the hole.
All three of the Converge shell components will use existing Inter-Op instrumentation and will mate with currently marketed Inter-Op Acetabular Inserts (oxygenless packaged polyethylene, Durasul, or Metasul).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Hip joint, Acetabulum
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3350 Hip joint metal/polymer semi-constrained cemented prosthesis.
(a)
Identification. A hip joint metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and an acetabular resurfacing component made of ultra-high molecular weight polyethylene and is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II.
0
OCT 1 8 2001
p 1/2
510(k) SUMMARY
In accordance with the Food and Drug Administration Rule to implement provisions of the Safe Medical Devices Act of 1990 and in conformance with 21 CFR 807, this is to serve as a Summary of Safety and Effectiveness for the Sulzer Orthopedics Converge Acetabular System.
| Manufacturer: | Sulzer Orthopedics Inc.
9900 Spectrum Drive
Austin, Texas 78717
(512) 432-9900 |
|-------------------------|-------------------------------------------------------------------------------------------------------|
| Date: | September 27, 2001 |
| Contact Person: | Mitchell A. Dhority
Director, Regulatory & Clinical Affairs |
| Classification Name: | Hip Joint Metal/Polymer/Metal Semi-constrained Porous-coated
Uncemented Prosthesis, 21CFR 888.3358 |
| Common/Usual Name: | Acetabular Shell Components |
| Trade/Proprietary Name: | Sulzer Orthopedics Converge Acetabular System |
PRODUCT DESCRIPTION
The Converge Acetabular System consists of the following shell components:
- I. Hemispherical
The Converge Hemispherical Shell is a porous coated, Ti-6A1-4V (ASTM F136) shell. The outer surface of the shell has CSTi porous coating (commercially pure titanium) to provide for biological fixation. The shell is available in various sizes ranging from 39mm to 65mm (in 2mm increments).
The shell features 2 screwhole plugs that are sintered in place. The screwhole plugs can be removed intraoperatively before or after implantation if the surgeon opts to enhance fixation of the shell with bone screws. When left in place (no supplemental screws used), the screwhole plugs limit material ingress and egress (e.g., tissue, debris particles, cement, etc.).
- II. Rim-Flare
The Converge Rim Flare Shell is a Ti-6AI-4V metallic acetabular shell coated with CSTi porous coating. It is designed with an offset outer radius in the rim region which permits the loads to be transmitted to the periphery of the outer surface. An initial press-fit of the component is achieved by the offset radius in this region. Additionally, the outer design of the shell incorporates three pegs which are press-fit into the cancellous bone of the reamed acetabulum to minimize the potential for tilting or rotation of the device. The shell is available in various sizes ranging from 39mm to 71mm (in 2mm increments).
1
K012961
P2/2
III. Revision
The Converge Revision Shell is a Ti-6Al-4V metallic acetabular shell coated with CSTi porous coating. The Revision shell has up to nine screwholes which allow for screw placement into the illum, ischium and pubis. Those screwholes that are not utilized may be plugged after implantation to limit passage of tissue, debris particles, cement, etc. The shell is available in various sizes ranging from 43mm (in 2mm increments).
All three Converge shells feature a central dome hole which allows for interface with the impactor/alignment instrument as well as for visualization of the acetabulum to ensure complete seating of the device. The dome hole may be plugged using a threaded cover to restrict unwanted material migration through the hole.
All three of the Converge shell components will use existing Inter-Op instrumentation and will mate with currently marketed Inter-Op Acetabular Inserts (oxygenless packaged polyethylene, Durasul, or Metasul).
SPECIFIC DIAGNOSTIC INDICATIONS
Components of the Converge Acetabular System are intended for use in total hip arthroplasty for treatment of the following:
- patient conditions of noninflammatory degenerative joint disease (NIDJD); e.g., avascular ● necrosis, osteoarthritis, and inflammatory joint disease (IJD), e.g., rheumatoid arthritis.
- those patients with failed previous surgery where pain, deformity, or dysfunction persists. ●
- revision of a previously failed arthroplasty where there is sufficient bone stock to support the . implant.
SUBSTANTIAL EQUIVALENCE
Substantial equivalence is based on comparison to the Inter-Op Acetabular System. The fundamental scientific technologies previously incorporated into the Inter-Op Acetabular System have not changed in the Converge Acetabular System. The main difference is relative to changes being made to the manufacturing process which should provide additional assurance of cleanliness. These manufacturing process changes have also necessitated some minor changes in design for the Converge, all of which were assessed relative to the Inter-Op and found to be acceptable.
Based on conformance with the design control requirements as specified in 21 CFR 820.30 and similarities in design, materials, sterilization, intended use and indications for use, we believe that the Converge Acetabular System is substantially equivalent to the previously cleared Inter-Op Acetabular System.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract image of an eagle or bird-like figure with stylized wings.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
OCT 1 8 2001
Mr. Mitchell A. Dhority Director, Regulatory & Clinical Affairs Sulzer Orthopedics Inc. 9900 Spectrum Drive Austin, Texas 78717
Re: K012961
Trade/Device Name: Converge Acetabular System Regulation Number: 21 CFR §888.3350 and §888.3358 Regulation Name: hip joint metal/polymer semi-constrained cemented prosthesis; hip joint metal/poly/metal semi-constrained porous-coated uncemented prosthesis Regulatory Class: Class II Product Code: JDI and LPH Dated: August 31, 2001 Received: September 4, 2001
Dear Mr. Dhority:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the referenced doove and no the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device mendments, or to devices that have been reclassified in accordance with the provisions of Amendinents, or to act 1100 and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general approvisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting (1 Mr), it may of such of Federal Regulations, Title 21, Parts 800 to 898. In your device can or foundsh further announcements concerning your device in the Federal Register.
3
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements meall that ITDA has made a deceminations administered by other Federal agencies. of the Act of ally I ederal states and reguirements, including, but not limited to: registration 1 ou must comply with an all also rise ling (21 CFR Part 801); good manufacturing practice allo listing (21 CFR Part 807), labelity systems (QS) regulation (21 CFR Part 820); and if requirents as set forth in the quality byovensions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) I mis letter will anow you to objak finding of substantial equivalence of your device to a premarket notification. - The PDF results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and If you desire specific acritor for your avitro diagnostic devices), please contact the Office of additionally 21 OFF F 8 4-4659. Additionally, for questions on the promotion and Compliance at (301) 59 to rease contact the Office of Compliance at (301) 594-4639. advertising or your arragulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under noutheation [21 OF ICT affor the Division of Small Manufacturers, International and the Act may be obtained its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Sincerely yours,
Mark N. Milliman
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
4
510(k) Number (if known): KO12961
Device Name: Converge Acetabular System
Indications for Use:
Components of the Converge Acetabular System are intended for use in total hip arthroplasty for treatment of the following:
- patient conditions of noninflammatory degenerative joint disease (NIDJD); e.g., avascular . patient Conditions of nominations of wisgint disease (IJD), e.g., rheumatoid arthritis.
- necrosis, osteourinitio, and minus surgery where pain, deformity, or dysfunction persists. .
- those patients with ranse provises where there is sufficient bone stock to support the . implant.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use X